179P Efficacy and safety of extended-interval dosing strategy of immune checkpoint inhibitors during the COVID-19 outbreak: Experience from a single center

Saved in:
Bibliographic Details
Published in:Journal of thoracic oncology 2021-04, Vol.16 (4), p.S794-S795
Main Authors: Pierre, C., Goter, T., Agar, C., Luzi, S., Lena, H., Guen, Y. Le, Ricordel, C.
Format: Article
Language:English
Subjects:
Advanced Nsclc
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1556-0864
1556-1380
DOI:10.1016/S1556-0864(21)02021-9